FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023097799> ?p ?o ?g. }

• W2023097799 endingPage "2207" @default.
• W2023097799 startingPage "2201" @default.
• W2023097799 abstract "Cytokines are powerful molecules that the bodys immune cells secrete in response to an offending agent. Their main function is to direct the immune response into the most effective pathway that will eventually result in elimination of the offender. The last decade was marked by an enormous and ever growing interest that led to discovery of numerous cytokine molecules and their amazing influence on the body immune function. The more we are learning about the way cytokines modulate and direct the immune responses of the body, the interest in using them or their antagonist to change or enhance those responses is growing. Studies are currently underway showing the beneficial effect of TNFa antagonists on the cellular injury mediated by this cytokine in rheumatic diseases, inflammatory bowel disease and endotoxemia. Interferon therapies are also tested utilizing IFNa for treatment of Hepatitis B and C. The discovery of Th1 and Th2 cytokines had shown that the nature of the immune response is, in essence, directed by a few important cytokines. Which immune reactions will develop seems to depend on whether IL-2 and IL-12 are secreted (and the immune response becomes Th1 with secretion of IFNγ and efficient removal of some antigens such as viruses) or IL-4 is secreted in which case Th2 response results in down regulation of IFN? and IL-2 secreting effectors. The discovery, isolation and purification of these molecules open the possibility to skew the immune response in order to facilitate better outcome. For example, studies have now being conducted aimed at using IL-2 as an adjuvant therapy in conjunction with HAART in HIV patients. Similarly, IL-12 seems to be beneficial in melanoma and has been used as a very potent adjuvant for eliciting immune responses to immunization. Furthermore, studies with IL-4 knockout mice and those utilizing IL-4 blocking agents have shown that this cytokine might play a crucial role in maintaining persistent viral infections and in mediating chronic, autoimmune diseases. Using bodys own immunomodulators is becoming an exciting possibility to target inefficient or misdirected immune responses that result in disease. The potential benefits in terms of human disease are enormous and still largely unexplained. Thus, using cytokines and their antagonists as therapeutic agents is an emerging and growing area of research. Keywords: tnf, interferon, il-2, cytokines" @default.
• W2023097799 created "2016-06-24" @default.
• W2023097799 creator A5034091192 @default.
• W2023097799 date "2002-12-01" @default.
• W2023097799 modified "2023-09-25" @default.
• W2023097799 title "Cytokines and their Antagonists as Therapeutic Agents" @default.
• W2023097799 doi "https://doi.org/10.2174/0929867023368656" @default.
• W2023097799 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12470242" @default.
• W2023097799 hasPublicationYear "2002" @default.
• W2023097799 type Work @default.
• W2023097799 sameAs 2023097799 @default.
• W2023097799 citedByCount "11" @default.
• W2023097799 countsByYear W20230977992015 @default.
• W2023097799 countsByYear W20230977992016 @default.
• W2023097799 countsByYear W20230977992021 @default.
• W2023097799 crossrefType "journal-article" @default.
• W2023097799 hasAuthorship W2023097799A5034091192 @default.
• W2023097799 hasConcept C17991360 @default.
• W2023097799 hasConcept C203014093 @default.
• W2023097799 hasConcept C2776178377 @default.
• W2023097799 hasConcept C2778690821 @default.
• W2023097799 hasConcept C49039625 @default.
• W2023097799 hasConcept C55493867 @default.
• W2023097799 hasConcept C71924100 @default.
• W2023097799 hasConcept C86803240 @default.
• W2023097799 hasConcept C8891405 @default.
• W2023097799 hasConceptScore W2023097799C17991360 @default.
• W2023097799 hasConceptScore W2023097799C203014093 @default.
• W2023097799 hasConceptScore W2023097799C2776178377 @default.
• W2023097799 hasConceptScore W2023097799C2778690821 @default.
• W2023097799 hasConceptScore W2023097799C49039625 @default.
• W2023097799 hasConceptScore W2023097799C55493867 @default.
• W2023097799 hasConceptScore W2023097799C71924100 @default.
• W2023097799 hasConceptScore W2023097799C86803240 @default.
• W2023097799 hasConceptScore W2023097799C8891405 @default.
• W2023097799 hasIssue "24" @default.
• W2023097799 hasLocation W20230977991 @default.
• W2023097799 hasLocation W20230977992 @default.
• W2023097799 hasOpenAccess W2023097799 @default.
• W2023097799 hasPrimaryLocation W20230977991 @default.
• W2023097799 hasRelatedWork W181678093 @default.
• W2023097799 hasRelatedWork W1991500760 @default.
• W2023097799 hasRelatedWork W1994050787 @default.
• W2023097799 hasRelatedWork W2005666125 @default.
• W2023097799 hasRelatedWork W2043331267 @default.
• W2023097799 hasRelatedWork W2047209980 @default.
• W2023097799 hasRelatedWork W2398878426 @default.
• W2023097799 hasRelatedWork W3138050922 @default.
• W2023097799 hasRelatedWork W2185732136 @default.
• W2023097799 hasRelatedWork W2396811992 @default.
• W2023097799 hasVolume "9" @default.
• W2023097799 isParatext "false" @default.
• W2023097799 isRetracted "false" @default.
• W2023097799 magId "2023097799" @default.
• W2023097799 workType "article" @default.